Photo by impulsq from unsplash
Pancreatic ductal adenocarcinoma (PDAC) presents as unresectable disease in 80% of patients. Limited Australian data exists regarding management and outcome of palliative management for PDAC. This study aims to: (i)… Click to show full abstract
Pancreatic ductal adenocarcinoma (PDAC) presents as unresectable disease in 80% of patients. Limited Australian data exists regarding management and outcome of palliative management for PDAC. This study aims to: (i) identify patients with PDAC being managed with palliative intent; (ii) assess the type of palliative management being used.
Keywords:
treatments unresectable;
unresectable pancreatic;
pancreatic cancer;
palliative treatments;
evaluation palliative;
management
Journal Title: ANZ Journal of Surgery
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: ANZ Journal of Surgery
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!